Pfizer (PFE) Trades Higher on Vaccine

The Stock is forming a Triangle Bullish Continuation Pattern...

USA (1)

Pfizer (PFE), a U.S. pharmaceutical giant, reported positive results from a trial of the Covid-19 vaccine it jointly developing with Germany's BioNTech. The Company also confirmed that the vaccine is on track to be submitted for regulatory review in October.

Last month, both companies obtained a $2 billion deal to supply the U.S. government with an initial 100 million doses of the vaccine. 

Meanwhile, Johnson & Johnson (JNJ), a vaccine-making competitor, announced plans to test its Covid-19 vaccine in 60,000 people, double the number tested in Pfizer's study.

In after-market hours, both Pfizer's and Johnson & Johnson's shares traded modestly higher.

On a Daily Chart, Pfizer (PFE) is forming a Triangle Bullish Continuation Pattern.

Sources: GAIN Capital, TradingView

A clear break above the upper boundary of the Triangle Pattern would call for a continued rally.

It has returned to levels above both 20-day and 50-day moving averages.

A continued uptrend should bring the stock back to $39.55 (around the recent high seen in late July).

Above that level, PFE should then aim at $40.95.(around the previous high seen in January).

Bullish investors should take the level of $37.25 (around the recent low seen in late July) as the Key Support (Stop-loss level).

More from Equities

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.